Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, and listed on the Toronto Stock Exchange (TMD) and the OTCQB in the U.S. (TITXF).
The Company is advancing the development of a robust product portfolio with the objective to meet current needs in surgical procedures which would benefit all stakeholders, including patients, surgeons, and hospitals. The Company’s robotic surgical system, currently under development, comprises a surgeon controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures. The robotic surgical system is being designed to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are currently underserviced, and to allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Titan is planning to commercialize its single incision surgical system first in Europe and then the United States, the world’s two largest markets.